2022
DOI: 10.24875/rma.m19000003
|View full text |Cite
|
Sign up to set email alerts
|

Ultrasonido vascular en la planeación terapéutica endovascular en pacientes con isquemia crítica

Abstract: La angiografía es el estándar de oro para evaluar la localización y extensión de la enfermedad arterial periférica (EAP). Sin embargo, es invasiva y confiere riesgo de nefrotoxicidad. El uso de ultrasonido dúplex vascular (USV) podría ser una alternativa no invasiva en lugar de la arteriografía. Nuestro objetivo es determinar si el USV es tan eficiente como la angiografía para el diagnóstico y plan terapéutico en la EAP. Material y métodos: Estudio observacional, de concordancia, en pacientes con EAP que fuero… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 11 publications
0
1
0
Order By: Relevance
“…It should be noted that revascularization by itself does not decrease the rate of amputation, the set of increased understanding of the DF pathophysiology, as well as advances in endovascular diagnostic and treatment techniques, stratification tools, and the development of treatment guidelines could be other causal factors. Indeed, advances in diagnostic techniques in particular help determine the status of DF-related complications before and after the initiation of endovascular therapies, thereby helping to determine future strategies, identify cost-effective tools, and optimize clinical outcomes 17 . There is little evidence supporting the hypothesis that revascularization is superior in reducing the number of amputations when compared to the following: risk detection and stratification, timely patient referral, patient education, and multidisciplinary care.…”
Section: Discussionmentioning
confidence: 99%
“…It should be noted that revascularization by itself does not decrease the rate of amputation, the set of increased understanding of the DF pathophysiology, as well as advances in endovascular diagnostic and treatment techniques, stratification tools, and the development of treatment guidelines could be other causal factors. Indeed, advances in diagnostic techniques in particular help determine the status of DF-related complications before and after the initiation of endovascular therapies, thereby helping to determine future strategies, identify cost-effective tools, and optimize clinical outcomes 17 . There is little evidence supporting the hypothesis that revascularization is superior in reducing the number of amputations when compared to the following: risk detection and stratification, timely patient referral, patient education, and multidisciplinary care.…”
Section: Discussionmentioning
confidence: 99%